about
Achieving optimal cancer outcomes in East Africa through multidisciplinary partnership: a case study of the Kenyan National Retinoblastoma Strategy groupChallenges faced by multidisplinary new investigators on addressing grand challenges in global health.Ethical, social, and cultural issues related to clinical genetic testing and counseling in low- and middle-income countries: protocol for a systematic reviewPeriocular topotecan for intraocular retinoblastoma.Retinoblastoma referral pattern in KenyaHand-held high-resolution spectral domain optical coherence tomography in retinoblastoma: clinical and morphologic considerations.The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.Cancer genetics education in a low- to middle-income country: evaluation of an interactive workshop for clinicians in Kenya.Retinoblastoma genetics in India: From research to implementation.Views from the Global South: exploring how student volunteers from the Global North can achieve sustainable impact in global health.Molecular testing prognostic of low risk in epithelioid uveal melanoma in a childDesign and Implementation of the Retinoblastoma Collaborative Laboratory.The genomic landscape of retinoblastoma: a review.Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review.Knowledge of genetics in familial retinoblastoma.How can a Theory of Change framework be applied to short-term international volunteering?Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.Quantitative analysis of tumor size in a murine model of retinoblastoma.The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development.Maintaining Research Integrity While Balancing Cultural Sensitivity: A Case Study and Lessons From the Field.Perceptions of the Role of Short-Term Volunteerism in International Development: Views from Volunteers, Local Hosts, and Community Members.The Voluntariat: A Frieirean framework to understand the nature of undergraduate international (medical) experiences.Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.Radiologic surveillance for retinoblastoma metastases unexpectedly showed disseminated toxocariasis in liver, lung, and spinal cord.Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma.Toxocariasis mimicking liver, lung, and spinal cord metastases from retinoblastoma.Prenatal versus Postnatal Screening for Familial Retinoblastoma.Digital cancer pathology in Africa.Trilateral retinoblastoma with pituitary-hypothalamic dysfunction."Where Does it Come from?" Experiences Among Survivors and Parents of Children with Retinoblastoma in Kenya.Knowledge, experiences and attitudes concerning genetics among retinoblastoma survivors and parents.Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single-institute experience.Retinoblastoma, the visible CNS tumor: A review.Evidence-based care for trilateral retinoblastoma.Developing clinical cancer genetics services in resource-limited countries: the case of retinoblastoma in Kenya.Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.Breaking down barriers to communicating complex retinoblastoma information: can graphics be the solution?Enucleation Refusal for Retinoblastoma: A Global Study.
P50
Q30384094-B90920BC-7AE2-41A0-9EFC-37EA87263B15Q33677770-CFCA84CA-4CA4-48F2-8B9E-04877B6F8307Q33893243-0F730B53-3040-4443-A5FD-E85594A9BF7FQ33931635-8FBFC107-C36B-4862-9A63-0ED8E31260FDQ34447847-148507AA-C381-49A8-9B55-2F6C8607A75AQ34459019-57CB19DF-90EB-4F48-8BCE-76D5050530A0Q35247713-BDD9653B-2ED8-4274-84C5-0B7E8931D9B0Q35650076-63BB2B04-F465-4B4D-93B1-2E2B9009FC38Q35663105-25BB9B59-6BBF-495D-ABCA-8C90B584A16AQ37070599-A4BCBEF3-C9F4-41BE-AB67-36C4F1DD9A73Q37137629-FD60CB62-A8BE-4ACE-A681-F67482724D99Q37654701-0385460D-E191-4E20-B0BD-7C33BFD262B2Q38179069-2F99F369-B137-4472-8146-B730765D9B7CQ38778214-A463C11E-88CE-4F01-8800-610D421CF501Q38900429-BC1658E2-B8AE-4126-96F8-6B4A338B1A8DQ38952728-637CD882-2415-4223-921E-4A7FE432B03EQ39180520-3F05FEEB-0B7A-4F44-ABFE-55A34C448D04Q39881502-00C5B813-1D48-476D-89DB-04976FC9BAEAQ40024982-C4C2CC2E-0A43-48CC-A519-B79D3C997DFFQ40549221-812BF51A-B376-477F-994A-D46A9EA23F0CQ41834991-18B57E37-71B0-455E-AE86-3EF960D1CED5Q42124359-E763FA5B-17A1-4734-8200-AA2227CC5412Q42971686-D26A2DB7-BE61-4154-B75F-D44F87FBB108Q43105363-2BB8DDA9-08D2-40BD-8A63-19841EE44BEAQ43235070-8E64F977-A485-47E0-AEF2-3C6D8D3E17D7Q43295098-8D10B6B4-398E-4844-B5B5-CE38E6E2BA0CQ44701247-80E446D9-A2DA-43E5-894B-CEC4812629D2Q46125757-66BF0710-A986-416B-85D4-124F56924B8FQ46186950-6D7912C4-7975-4E9C-A50D-33A789C390A3Q46228535-E377859C-691C-4CB1-ACC4-8C9907D0A9B1Q46394238-A26A3633-82EF-4733-B119-F3B4A772BDB0Q47420854-A896926F-E8A6-4B07-84E4-2ADFA825A34AQ47706186-6870D8CF-09E6-442D-9840-D54A9D7B159AQ48208949-59840EF0-5A10-47EA-B103-A4597501A994Q48288706-C1ACE396-F239-407D-A89C-0CCC91AE652CQ48602388-510680D7-5CFC-4AD3-8D83-06710ED56DB9Q49744627-9464BEB0-802D-4C54-A090-BFA995E3AD63Q50335530-39E0E0A8-A820-4427-9181-4386775166CAQ50548360-A93D1CA4-A248-4896-A05B-9C9DF0EEC011Q51807476-E46583D3-6690-4B96-9E84-E83F18D328E6
P50
description
researcher ORCID ID = 0000-0003-1164-2001
@en
name
Helen Dimaras
@ast
Helen Dimaras
@en
Helen Dimaras
@es
Helen Dimaras
@nl
type
label
Helen Dimaras
@ast
Helen Dimaras
@en
Helen Dimaras
@es
Helen Dimaras
@nl
prefLabel
Helen Dimaras
@ast
Helen Dimaras
@en
Helen Dimaras
@es
Helen Dimaras
@nl
P21
P31
P496
0000-0003-1164-2001